Nahdi Medical Company
Saudi Stock Exchange 4164.SR
Nahdi Medical Company Free Cash Flow Yield on January 14, 2025: 6.35%
-
Nahdi Medical Company 52-week high Free Cash Flow Yield is 6.56% on November 27, 2024, which is 3.36% above the current Free Cash Flow Yield.
-
Nahdi Medical Company 52-week low Free Cash Flow Yield is 4.94% on March 26, 2024, which is -22.17% below the current Free Cash Flow Yield.
-
Nahdi Medical Company average Free Cash Flow Yield for the last 52 weeks is 5.77%.
| Date | Free Cash Flow Yield | Market Value Added (MVA) | Price to Book Ratio (P/B) | Price to Earnings Ratio (P/E) |
|---|
| CEO | Mr. Yasser Ghulam Bin Abdulaziz Joharji |
| IPO Date | April 18, 2022 |
| Location | Saudi Arabia |
| Headquarters | Abraq Al-Roghamah District |
| Employees | 5,169 |
| Sector | Health Care |
| Industries | |
Nahdi Medical Company operates as a pharmaceutical retailer in the Kingdom of Saudi Arabia and the United Arab Emirates. The company offers pharmaceutical and health products, such as medicine, wellness, mom and baby, beauty, and other FMCG products. It also provides omni-health services through its polyclinics, express clinics, telemedicine, labs, and home healthcare. In addition, the company engages in the wholesale and retail trading of cosmetics, pharmaceutical products, special and healthy foods, and medical equipment. It operates approximately 1,151 pharmacies. The company was founded in 1986 and is headquartered in Jeddah, the Kingdom of Saudi Arabia. Nahdi Medical Company operates as a subsidiary of Alnahdi Holding Company Limited and Saudi Economic and Development Company Limited.
Past 5 years
USD 20.64
USD 313.79
USD 17.42
USD 78.21
USD 106.72
StockViz Staff
January 15, 2025
Any question? Send us an email